SS
Subramani Sudhakar
About Subramani Sudhakar
Data last updated:
Subramani Sudhakar has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Elixir Tools And Specialities Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Elixir Tools And Specialities Private Limited at ₹11.70 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Elixir Tools And Specialities Private Limited U74900TN2010PTC075761 | Director | 20 May 2010 | 2010 | ₹11.70 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subramani Sudhakar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subramani Sudhakar
Subramani Sudhakar has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Elixir Tools And Specialities Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Elixir Tools And Specialities Private Limited at ₹11.70 Cr (FY 2024).
Subramani Sudhakar is associated with 1 company as Director, including Elixir Tools And Specialities Private Limited (₹11.70 Cr).
Subramani Sudhakar has expertise in General Business.
Subramani Sudhakar has 16 years in corporate governance.
By reported revenue, the largest current company of Subramani Sudhakar is Elixir Tools And Specialities Private Limited, with revenue of ₹11.70 Cr (FY 2024).
Subramani Sudhakar currently holds positions at 1 company: Elixir Tools And Specialities Private Limited (₹11.70 Cr).